Abot, A.; Fontaine, C.; Buscato, M.; Solinhac, R.; Flouriot, G.; Fabre, A.; Drougard, A.; Rajan, S.; Laine, M.; Milon, A.; et al. The uterine and vascular actions of estetroldelineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. EMBO Mol. Med. 2014, 6, 1328–1346. [CrossRef] [PubMed]
Valéra, M.C.; Noirrit-Esclassan, E.; Dupuis, M.; Fontaine, C.; Lenfant, F.; Briaux, A.; Cabou, C.; Garcia, C.; Lairez, O.; Foidart, J.M.; et al. Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis. Mol. Cell. Endocrinol. 2018, 477, 132–139. [CrossRef]
Benoit, T.; Valera, M.C.; Fontaine, C.; Buscato, M.; Lenfant, F.; Raymond-Letron, I.; Tremollieres, F.; Soulie, M.; Foidart, J.M.; Game, X.; et al. Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation. Am. J. Pathol. 2017, 187, 2499–2507. [CrossRef]
Foidart, J.M.; Gaspard, U.; Pequeux, C.; Jost, M.; Gordenne, V.; Tskitishvili, E.; Gallez, A.; Valera, M.C.; Gourdy, P.; Fontaine, C.; et al. Unique Vascular Benefits of Estetrol, a Native Fetal Estrogen with Specific Actions in Tissues (NEST). In Sex Steroids’ Effects on Brain, Heart and Vessels; Springer: Cham, Switzerland, 2019; pp. 169–195. [CrossReCrossRef] c